ArticleBMC cancer2024

Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target.

Dongshan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.